Physician profile

Percy H Lo

Plastic and Reconstructive Surgery · St Petersburg, FL

NPI 1518954288

$17,417.39

in general payments reported to CMS, 2019-2025

35 companies · $4,610 in 2025

The $4,610 reported for 2025 was more than what 92% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).

See the full distribution for Plastic and Reconstructive Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Honoraria$5,100.00
Food and Beverage$4,010.16
Travel and Lodging$1,285.11
Long Term Medical Supply Or Device Loan$652.00
Consulting Fee$500.00
Gift$87.00
Education$8.45

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Davol INC. $3,931.64 2024-2025 Arista
Tela Bio, INC. $2,876.69 2021-2024 Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s
Sientra, INC. $2,506.70 2019-2022
Rti Surgical, INC $1,427.49 2023-2025
Abbvie INC. $1,397.73 2022-2025
Motiva USA, LLC $1,263.14 2024-2025
Integra Lifesciences Corporation $840.57 2022-2024 Durasorb Monofilament Mesh, Integra, Primatrix
Allergan, INC. $441.30 2019-2022
Organogenesis INC. $420.14 2019-2024 Puraply
Smith+Nephew, INC. $298.56 2019-2024 Collagenase Santyl, Stravix, Grafix Pl
Convatec INC. $238.61 2023-2025
Mentor Worldwide LLC $213.69 2021-2025 Mentor Memorygel Resterilizable Gel Sizer
Musculoskeletal Transplant Foundation INC. $195.63 2025
Revance Therapeutics, INC. $180.42 2024-2025 Daxxify
Solventum Corporation $144.25 2024-2025 Prevena, V.A.C. Veraflo, Activ.A.C.
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Genentech USA, INC. $140.17 2019
Baxter Healthcare $124.15 2024 Artiss
Intuitive Surgical, INC. $119.17 2025
Merz North America, INC. $79.05 2023-2024 Xeomin
Kerecis Limited $73.16 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Acera Surgical, INC. $67.25 2019-2024 Restrata Wound Matrix
Mimedx Group, INC. $65.63 2025
Hydrofera LLC $61.68 2023-2024 Cutimed Sorbion, Cutimed Sorbact
Surgenex LLC $52.96 2025 Surmatrix, Pellograft, Renograft
Avita Medical Americas, LLC $41.70 2025 Cohealyx, Recell, Permeaderm
Biocircuit Technologies INC $40.80 2025 Nerve Tape
Acell, INC. $33.24 2019-2020
Solta Medical, A Division of Bausch Health US, LLC $22.92 2024 Clear+Brilliant
Polynovo North America LLC $21.81 2025 Novosorb Btm
Medtronic, INC. $21.69 2023 Plasmablade(Tm)
Molnlycke Health Care US, LLC $19.99 2019
Sanara Medtech INC. $16.58 2022
Medline Industries LP $14.88 2020
Innovation Technologies INC $12.52 2022
Melinta Therapeutics, LLC $11.48 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Percy H Lo

$17,417.39

in general payments reported 2019-2025

Years
2019-2025
Top company
Davol INC.
Context
The $4,610 reported for 2025 was more than what 92% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).

https://glasscript.com/doctor/520517/percy-h-lo

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.